Overview

Efficacy and Safety of Oxycodone/Naloxone (Targin®) in Persistent Moderate to Severe Low Back Pain Following NSAIDs Treatment

Status:
Completed

Trial end date:
2020-09-17

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the efficacy of the study drug (Targin®) after 8 weeks of treatment in patients with moderate to severe low back pain who are uncontrolled* by NSAIDs.

Phase:

Phase 4

Details

Lead Sponsor:

Mundipharma Korea Ltd

Treatments:

Naloxone
Oxycodone